Maze Therapeutics, Inc. · NASDAQ:MAZE
Janus Henderson Group PLC reported a 7.30% stake in Maze Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Janus Henderson Group PLC reported a 7.30% stake in Maze Therapeutics, Inc., 3,206,472 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 7.30%
- Shares
- 3,206,472
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.30% | 3,206,472 |
Source
Related
- Maze Therapeutics, Inc.
- Janus Henderson Group PLC
- Maze Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G · Janus Henderson Group PLC · May 14, 2025
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026